Oprl1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Oprl1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Oprl1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Oprl1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPRM1 Human Pre-designed siRNA Set A contains three designed siRNAs for OPRM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPRPN Human Pre-designed siRNA Set A contains three designed siRNAs for OPRPN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPTC Human Pre-designed siRNA Set A contains three designed siRNAs for OPTC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPTN Human Pre-designed siRNA Set A contains three designed siRNAs for OPTN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OR1A1 Human Pre-designed siRNA Set A contains three designed siRNAs for OR1A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OR1A2 Human Pre-designed siRNA Set A contains three designed siRNAs for OR1A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OR2AT4 Human Pre-designed siRNA Set A contains three designed siRNAs for OR2AT4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OR2H1 Human Pre-designed siRNA Set A contains three designed siRNAs for OR2H1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OR2M7 Human Pre-designed siRNA Set A contains three designed siRNAs for OR2M7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OR4F17 Human Pre-designed siRNA Set A contains three designed siRNAs for OR4F17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OR4F5 Human Pre-designed siRNA Set A contains three designed siRNAs for OR4F5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OR51E1 Human Pre-designed siRNA Set A contains three designed siRNAs for OR51E1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OR51E2 Human Pre-designed siRNA Set A contains three designed siRNAs for OR51E2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OR5B21 Human Pre-designed siRNA Set A contains three designed siRNAs for OR5B21 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OR6A2 Human Pre-designed siRNA Set A contains three designed siRNAs for OR6A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OR7D4 Human Pre-designed siRNA Set A contains three designed siRNAs for OR7D4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ORAI1 Human Pre-designed siRNA Set A contains three designed siRNAs for ORAI1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ORAI2 Human Pre-designed siRNA Set A contains three designed siRNAs for ORAI2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ORAI3 Human Pre-designed siRNA Set A contains three designed siRNAs for ORAI3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ORC1 Human Pre-designed siRNA Set A contains three designed siRNAs for ORC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ORC2 Human Pre-designed siRNA Set A contains three designed siRNAs for ORC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ORC3 Human Pre-designed siRNA Set A contains three designed siRNAs for ORC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ORC4 Human Pre-designed siRNA Set A contains three designed siRNAs for ORC4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ORC5 Human Pre-designed siRNA Set A contains three designed siRNAs for ORC5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ORC6 Human Pre-designed siRNA Set A contains three designed siRNAs for ORC6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Orforglipron hemicalcium hydrate (LY3502970 hemicalcium hydrate; GLP-1 receptor agonist 1 hemicalcium hydrate) is the calcium salt hydrate form of Orforglipron (HY-112185). Orforglipron is an orally active agonist for Glucagon-like peptide-1 receptor (GLP-1R), which exhibits potency in ameliorating the type 2 diabete[1].

Orforglipron hemicalcium hydrate (LY3502970 hemicalcium hydrate; GLP-1 receptor agonist 1 hemicalcium hydrate) is the calcium salt hydrate form of Orforglipron (HY-112185). Orforglipron is an orally active agonist for Glucagon-like peptide-1 receptor (GLP-1R), which exhibits potency in ameliorating the type 2 diabete[1].

Orforglipron hemicalcium hydrate (LY3502970 hemicalcium hydrate; GLP-1 receptor agonist 1 hemicalcium hydrate) is the calcium salt hydrate form of Orforglipron (HY-112185). Orforglipron is an orally active agonist for Glucagon-like peptide-1 receptor (GLP-1R), which exhibits potency in ameliorating the type 2 diabete[1].

Orforglipron hemicalcium hydrate (LY3502970 hemicalcium hydrate; GLP-1 receptor agonist 1 hemicalcium hydrate) is the calcium salt hydrate form of Orforglipron (HY-112185). Orforglipron is an orally active agonist for Glucagon-like peptide-1 receptor (GLP-1R), which exhibits potency in ameliorating the type 2 diabete[1].

Orforglipron hemicalcium hydrate (LY3502970 hemicalcium hydrate; GLP-1 receptor agonist 1 hemicalcium hydrate) is the calcium salt hydrate form of Orforglipron (HY-112185). Orforglipron is an orally active agonist for Glucagon-like peptide-1 receptor (GLP-1R), which exhibits potency in ameliorating the type 2 diabete[1].

ORIC-533 is an orally active, selective CD73 inhibitor with AMP-competition. ORIC-533 restores immunosuppressed CD8+ T cell proliferation and activation, triggers significant lysis and cell death of multiple myeloma cells in the bone marrow microenvironment[1].

ORIC-944 is a selective, orally active, allosteric inhibitor targeting the EED subunit of polycomb repressive complex 2 (PRC2). ORIC-944 is synergistic with androgen receptor pathway inhibitors (ARPIs) for the study of metastatic prostate cancer.

ORIC-944 is a selective, orally active, allosteric inhibitor targeting the EED subunit of polycomb repressive complex 2 (PRC2). ORIC-944 is synergistic with androgen receptor pathway inhibitors (ARPIs) for the study of metastatic prostate cancer.

ORIC-944 is a selective, orally active, allosteric inhibitor targeting the EED subunit of polycomb repressive complex 2 (PRC2). ORIC-944 is synergistic with androgen receptor pathway inhibitors (ARPIs) for the study of metastatic prostate cancer.

ORIC-944 is a selective, orally active, allosteric inhibitor targeting the EED subunit of polycomb repressive complex 2 (PRC2). ORIC-944 is synergistic with androgen receptor pathway inhibitors (ARPIs) for the study of metastatic prostate cancer.

ORIC-944 is a selective, orally active, allosteric inhibitor targeting the EED subunit of polycomb repressive complex 2 (PRC2). ORIC-944 is synergistic with androgen receptor pathway inhibitors (ARPIs) for the study of metastatic prostate cancer.

ORL1 antagonist 2 (1B) is an opioid receptor-Like 1 (ORL1) antagonist, usd in P-glycoprotein (P-gp) research[1].

ORM1 Human Pre-designed siRNA Set A contains three designed siRNAs for ORM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ORM2 Human Pre-designed siRNA Set A contains three designed siRNAs for ORM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ORMDL3 Human Pre-designed siRNA Set A contains three designed siRNAs for ORMDL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Orotic acid (Standard) is the analytical standard of Orotic acid. This product is intended for research and analytical applications. Orotic acid (6-Carboxyuracil), a precursor in biosynthesis of pyrimidine nucleotides and RNA, is released from the mitochondrial dihydroorotate dehydrogenase (DHODH) for conversion to UMP by the cytoplasmic UMP synthase enzyme. Orotic acid is a marker for […]

Orotic acid (Standard) is the analytical standard of Orotic acid. This product is intended for research and analytical applications. Orotic acid (6-Carboxyuracil), a precursor in biosynthesis of pyrimidine nucleotides and RNA, is released from the mitochondrial dihydroorotate dehydrogenase (DHODH) for conversion to UMP by the cytoplasmic UMP synthase enzyme. Orotic acid is a marker for […]